Steiner Jill M, Cooper Stephanie, Kirkpatrick James N
Division of Cardiology, University of Washington, Seattle, Washington, USA.
Division of Cardiology, Harborview Medical Center, Seattle, Washington, USA.
Heart. 2017 Aug;103(16):1233-1237. doi: 10.1136/heartjnl-2016-310538.
Valvular heart disease (VHD), particularly aortic valve disease, is prevalent with increasing incidence. When surgery is not possible, or when risks outweigh benefits, percutaneous treatment options may offer effective alternatives. However, procedures may not always go as planned, and frail patients or those whose symptoms are caused by other comorbidities may not benefit from valve intervention at all. Significant effort should be made to assess frailty, comorbidities and patient goals prior to intervention. Palliative care (PC) should play a critical role in the care of patients with severe valve disease. PC is specialised medical care that aims to optimise health-related quality of life by managing symptoms and clarifying patient values and goals of care. It should be implemented at the time of diagnosis and continue throughout the disease course. Because of the paucity of studies dedicated to the provision of PC to patients with advanced VHD, further research is needed.
心脏瓣膜病(VHD),尤其是主动脉瓣疾病,发病率日益上升,十分常见。当无法进行手术或风险大于收益时,经皮治疗方案可能是有效的替代选择。然而,手术过程可能并不总是按计划进行,体弱的患者或那些症状由其他合并症引起的患者可能根本无法从瓣膜干预中获益。在进行干预之前,应付出巨大努力评估患者的虚弱程度、合并症情况及患者目标。姑息治疗(PC)在重症瓣膜病患者的护理中应发挥关键作用。姑息治疗是一种专门的医疗护理,旨在通过管理症状以及明确患者的价值观和护理目标,优化与健康相关的生活质量。它应在诊断时实施,并贯穿疾病全过程。由于专门针对晚期心脏瓣膜病患者提供姑息治疗的研究较少,因此需要进一步开展研究。